Dr. Egbert Saavedra is a Tucson, Arizona based male Ophthalmologist who is specialized in Ophthalmology. Active license number of Dr. Egbert Saavedra is 35251 in Arizona. Dr. Egbert Saavedra is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Dr. Egbert Saavedra speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Credentials:
M.D.
Gender:
Male
Practice Address:
6561 E Carondelet Dr, Tucson, Arizona, 85710-2156
Phone:
520-886-2597
Fax:
520-886-6639
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1518925858
NPI Enumeration Date:
03 May, 2006
NPI Last Update On:
05 Apr, 2017
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Egbert Saavedra are as mentioned below.
License Number
Specialization
State
Status
35251
Arizona
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
6561 E Carondelet Dr, Tucson, Arizona
Zip:
85710-2156
Phone Number:
520-886-2597
Fax Number:
520-886-6639
Patients can reach Dr. Egbert Saavedra at 6561 E Carondelet Dr, Tucson, Arizona or can call to book an appointment on 520-886-2597. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.